Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions. (Q37435425)
scientific article published on 06 April 2009
Language:
(P31) (Q13442814)
(Q7318358)
(P50) (Q37828902)
(Q56380768)
(Q37828910)
(P304) 378-390
(P433) 4
(P478) 14
(P577) Monday, April 6, 2009
(P921) (Q111140)
(Q7914515)
(P1433) (Q2122327)
(P1476) "Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions" (language: en)
(P2093) Fabiano Falasconi
Gianfranco De Feo
Antonia Del Giudice
Jane Bryce
Ermelinda De Maio
Francesco Perrone
Maria Carmela Piccirillo
other details
description scientific article published on 06 April 2009

External Links